Equity-Based Compensation - Stock Option Activity (Details) - Stock Options $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Jan. 31, 2024 USD ($) $ / shares shares	Apr. 30, 2023 USD ($) $ / shares shares
Number of Options
Outstanding, beginning of the period (in shares) | shares	1,106
Options granted (in shares) | shares	151
Options exercised (in shares) | shares	(228)
Options forfeited (in shares) | shares	(13)
Outstanding, end of the period (in shares) | shares	1,016	1,106
Exercisable at end of period (in shares) | shares	680
Vested and expected to vest at end of period (in shares) | shares	1,015
Weighted Average Exercise Price
Outstanding, beginning of period (in dollars per share) | $ / shares	$ 32.60
Options granted (in dollars per share) | $ / shares	74.75
Options exercised (in dollars per share) | $ / shares	22.12
Options forfeited (in dollars per share) | $ / shares	42.11
Outstanding, end of the period (in dollars per share) | $ / shares	41.11	$ 32.60
Exercisable at end of period (in dollars per share) | $ / shares	30.63
Vested and expected to vest at end of period (in dollars per share) | $ / shares	$ 41.11
Other disclosures
Weighted Average Remaining Contractual Life, Outstanding (in years)	6 years 9 months 18 days	6 years 6 months
Weighted Average Remaining Contractual Life, Exercisable at end of period (in years)	5 years 9 months 18 days
Weighted Average Remaining Contractual Life, Vested and expected to vest at end of period (in years)	6 years 9 months 18 days
Aggregate Intrinsic Value, Outstanding | $	$ 43,710	$ 28,155
Aggregate Intrinsic Value, Exercisable at end of period | $	36,409
Aggregate Intrinsic Value, Vested and expected to vest at end of period | $	$ 43,701